Omnicell Shares Outstanding 2010-2024 | OMCL

Omnicell shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Omnicell Annual Shares Outstanding
(Millions of Shares)
2023 45
2022 46
2021 48
2020 44
2019 43
2018 41
2017 39
2016 37
2015 37
2014 37
2013 36
2012 34
2011 34
2010 34
2009 32
Omnicell Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 46
2024-06-30 46
2024-03-31 46
2023-12-31 45
2023-09-30 46
2023-06-30 45
2023-03-31 45
2022-12-31 46
2022-09-30 46
2022-06-30 46
2022-03-31 48
2021-12-31 48
2021-09-30 48
2021-06-30 47
2021-03-31 46
2020-12-31 44
2020-09-30 44
2020-06-30 43
2020-03-31 44
2019-12-31 43
2019-09-30 43
2019-06-30 43
2019-03-31 42
2018-12-31 41
2018-09-30 41
2018-06-30 40
2018-03-31 40
2017-12-31 39
2017-09-30 39
2017-06-30 38
2017-03-31 37
2016-12-31 37
2016-09-30 37
2016-06-30 36
2016-03-31 36
2015-12-31 37
2015-09-30 37
2015-06-30 37
2015-03-31 37
2014-12-31 37
2014-09-30 37
2014-06-30 37
2014-03-31 36
2013-12-31 36
2013-09-30 36
2013-06-30 35
2013-03-31 35
2012-12-31 34
2012-09-30 34
2012-06-30 34
2012-03-31 34
2011-12-31 34
2011-09-30 34
2011-06-30 34
2011-03-31 34
2010-12-31 34
2010-09-30 34
2010-06-30 33
2010-03-31 33
2009-12-31 32
2009-09-30 32
2009-06-30 32
2009-03-31 31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.263B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00